Stanford University's Innovative Medicines Accelerator (IMA) and Intonation Research Laboratories (Intonation) have formed a collaboration to develop treatments that target cancerous neuroendocrine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results